VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
IMRX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
IMRXImmuneering Corporation
$5.10$185M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksIMRXQuarterly Financials

Immuneering Corporation (IMRX) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Immuneering Corporation (IMRX) quarterly income statement — complete revenue, gross profit & net income history

IMRX Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue000000000000045538.38K94.42K183.7K189.59K482.13K660.04K
Revenue Growth %----------100%-100%-100%-100%-99.76%-92.04%-85.69%-75.45%-71.49%--
Cost of Goods Sold180.48K612.73K000174.65K000185.22K0193.51K0019.34K250.29K90.85K206.22K219.09K318.6K
COGS % of Revenue--------------50.4%265.09%49.45%108.77%45.44%48.27%
Gross Profit-180.48K-612.73K000-174.65K000-185.22K0-193.51K045519.04K-155.87K92.85K-16.63K263.04K341.44K
Gross Margin %-------------100%49.6%-165.09%50.55%-8.77%54.56%51.73%
Gross Profit Growth %--250.84%---5.71%-100%--40806.81%-100%-24.15%-100%102.74%-92.76%-145.65%-72.61%-108.67%--
Operating Expenses15.15M13.14M15.38M14.76M15.48M18.38M15.27M14.91M15.33M16.12M13.93M13.31M14.68M13.99M13.21M11.49M13.02M11.1M8.81M8.33M
OpEx % of Revenue-------------3073727.91%34411.64%12169.35%7086.91%5854.25%1826.57%1262.4%
Selling, General & Admin4.68B4.51M4.5M4.3M4.01M3.59M4.01M4.25M4.12M4.27M3.87M3.91M4.38M4.11M3.84M3.55M3.95M3.15M2.6M1.34M
SG&A % of Revenue-------------902637.36%9994.79%3757.83%2151.36%1660.75%539.07%203.02%
Research & Development10.65B9.31M10.87M10.45M11.47M14.8M11.25M10.65M11.2M11.85M10.05M9.4M10.21M9.87M9.36M7.94M9.06M7.95M6.21M6.99M
R&D % of Revenue-------------2169617.8%24397.7%8411.52%4931.22%4193.49%1287.51%1059.32%
Other Operating Expenses-1000K-684.31K7.72K7.73K6.96K06.9K7.79K7.34K07.14K087.65K6.7K7.35K07.97K0-60398
Operating Income-15.34M-13.75M-15.38M-14.76M-15.48M-18.56M-15.27M-14.91M-15.33M-16.3M-13.93M-13.5M-14.68M-13.99M-13.19M-11.65M-12.93M-11.12M-8.54M-7.99M
Operating Margin %--------------3073627.91%-34362.04%-12334.43%-7036.37%-5863.02%-1772.01%-1210.67%
Operating Income Growth %0.97%25.89%-0.7%1.04%-1.04%-13.84%-9.68%-10.43%-4.4%-16.57%-5.6%-15.96%-13.57%-25.81%-54.37%-45.74%-107.27%-90.45%--
EBITDA-15.15M-13.32M-15.29M-14.67M-15.39M-18.38M-15.18M-14.82M-15.23M-16.12M-13.84M-13.31M-14.6M-13.8M-13.11M-11.44M-12.73M-11.06M-8.51M-7.96M
EBITDA Margin %--------------3032029.01%-34165.6%-12120.11%-6927.15%-5835.33%-1764.22%-1205.35%
EBITDA Growth %1.54%27.52%-0.77%1.01%-1.08%-14.06%-9.66%-11.3%-4.33%-16.82%-5.55%-16.32%-14.7%-24.7%-54.16%-43.84%-105.17%-89.8%--
D&A (Non-Cash Add-back)180.48K428.31K86.16K91.84K92.58K174.65K96.27K97.85K97.53K185.22K85.61K193.51K83.84K189.28K75.39K202.36K200.63K52.5K37.57K35.11K
EBIT-15.34M-14.17M-15.38M-14.76M-15.49M-18.05M-15.27M-14.91M-15.33M-15.08M-13.93M-12.19M-14.6M-13.99M-13.19M-11.53M-12.93M-11.12M-8.54M-7.99M
Net Interest Income1.36M-413.55M415.83K324.01K438.52K415.24K547.07K826.1K804.88K754.14K855.53K1.17M831.27K516.17K222.99K142.8K132.51K142.88K17.4K3.26K
Interest Income1.36M-413.55M415.83K324.01K438.52K415.24K547.07K826.1K804.88K754.14K855.53K1.17M831.27K516.17K222.99K142.8K132.51K142.88K17.4K3.26K
Interest Expense00000000000000000000
Other Income/Expense1.87M2.17M416.24K324.43K438.16K506.67K675.96K834.29K1.02M1.22M1.33M1.32M1.16M738.83K343.85K118.75K29.15K23.91K9.25K3.66K
Pretax Income-13.46M-11.58M-14.96M-14.43M-15.05M-18.05M-14.6M-14.08M-14.31M-15.08M-12.6M-12.19M-13.52M-13.25M-12.84M-11.53M-12.9M-11.09M-8.53M-7.99M
Pretax Margin %--------------2911247.47%-33466.12%-12208.67%-7020.49%-5850.41%-1770.09%-1210.12%
Income Tax00000000000000000-307.49K00
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%2.77%0%0%
Net Income-13.46M-11.58M-14.96M-14.43M-15.05M-18.05M-14.6M-14.08M-14.31M-15.08M-12.6M-12.19M-13.6M-13.25M-12.84M-11.53M-12.9M-10.78M-8.53M-7.99M
Net Margin %--------------2911112.31%-33466.21%-12208.67%-7020.42%-5688.22%-1770.08%-1210.18%
Net Income Growth %10.54%35.85%-2.52%-2.51%-5.16%-19.68%-15.9%-15.52%-5.17%-13.88%1.94%-5.74%-5.49%-22.82%-50.51%-44.31%-107.02%-84.79%--
Net Income (Continuing)-13.46M-11.58M-14.96M-14.43M-15.05M-18.05M-14.6M-14.08M-14.31M-15.08M-12.6M-12.19M-13.52M-13.25M-12.84M-11.53M-12.9M-10.78M-8.53M-7.99M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.21-0.18-0.38-0.40-0.42-0.58-0.49-0.47-0.49-0.52-0.43-0.4340.16-0.47-0.47-0.44-0.49-0.42-0.47-0.33
EPS Growth %50%68.97%22.45%14.89%14.29%-11.54%-13.95%-9.3%-101.22%-10.64%8.51%2.27%8295.92%-11.9%0%-33.33%-6.52%2.33%--
EPS (Basic)-0.21-0.18-0.38-0.40-0.42-0.58-0.49-0.47-0.49-0.52-0.43-0.4340.16-0.47-0.47-0.44-0.49-0.42-0.47-0.33
Diluted Shares Outstanding44.01M44.01M39.67M35.99M35.53M31.05M29.84M29.65M29.37M29.27M29.27M28.65M26.44M26.41M26.39M26.39M26.36M25.98M18.29M23.89M
Basic Shares Outstanding44.01M44.01M39.67M35.99M35.53M31.05M29.84M29.65M29.37M29.27M29.27M28.65M26.44M26.41M26.39M26.39M26.36M25.98M18.29M23.89M
Dividend Payout Ratio--------------------